MAM
RVLP

Martingale Asset Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Martingale Asset Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,800
Closed -$62K – 916
2021
Q1 		$62K Sell
18,800
-6,109
-25% -$25.1K ﹤0.01% 834
2020
Q4 		$103K Sell
24,909
-39,547
-61% -$228K ﹤0.01% 863
2020
Q3 		$349K Buy
64,456
+3,713
+6% +$21.4K ﹤0.01% 881
2020
Q2 		$409K Buy
60,743
+6,003
+11% +$29.4K ﹤0.01% 910
2020
Q1 		$175K Buy
54,740
+6,700
+14% +$35.7K ﹤0.01% 937
2019
Q4 		$336K Buy
+48,040
New +$256K ﹤0.01% 912

Other funds holding RVLP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Martingale Asset Management's RVLP Position: Q2 2021 in Review

Martingale Asset Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2021, closing a stake of 18,800 shares — an estimated $62K sold.

Martingale Asset Management first reported a position in RVLP in Q4 2019 and held it in 6 quarters. The position peaked at $409K in Q2 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q2 2021.

  • Martingale Asset Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Martingale Asset Management sold 18,800 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2021, an estimated $62K.
  • Martingale Asset Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 6 quarters.
  • Martingale Asset Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $409K in Q2 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2021.

Based on Martingale Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.